JPWO2022224962A1 - - Google Patents
Info
- Publication number
- JPWO2022224962A1 JPWO2022224962A1 JP2023515479A JP2023515479A JPWO2022224962A1 JP WO2022224962 A1 JPWO2022224962 A1 JP WO2022224962A1 JP 2023515479 A JP2023515479 A JP 2023515479A JP 2023515479 A JP2023515479 A JP 2023515479A JP WO2022224962 A1 JPWO2022224962 A1 JP WO2022224962A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021071269 | 2021-04-20 | ||
| PCT/JP2022/018192 WO2022224962A1 (ja) | 2021-04-20 | 2022-04-19 | 脂質異常症又は心臓血管病の予防・治療のための組合せ医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022224962A1 true JPWO2022224962A1 (enExample) | 2022-10-27 |
Family
ID=83723354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515479A Pending JPWO2022224962A1 (enExample) | 2021-04-20 | 2022-04-19 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240197688A1 (enExample) |
| EP (1) | EP4327826A4 (enExample) |
| JP (1) | JPWO2022224962A1 (enExample) |
| KR (1) | KR20230172463A (enExample) |
| CN (1) | CN117120093A (enExample) |
| AU (1) | AU2022262535A1 (enExample) |
| BR (1) | BR112023021643A2 (enExample) |
| CA (1) | CA3215775A1 (enExample) |
| WO (1) | WO2022224962A1 (enExample) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020033919A1 (en) * | 2018-08-10 | 2020-02-13 | Diapin Therapeutics, Llc | Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2404890T (pt) | 2003-01-23 | 2017-10-23 | Esperion Therapeutics Inc | Compostos de hidroxilo e composições para gestão do colesterol e utilizações relacionadas |
| AU2004270538C1 (en) | 2003-09-03 | 2010-01-14 | Kowa Co., Ltd | PPAR-activating compound and pharmaceutical composition containing same |
-
2022
- 2022-04-19 JP JP2023515479A patent/JPWO2022224962A1/ja active Pending
- 2022-04-19 BR BR112023021643A patent/BR112023021643A2/pt unknown
- 2022-04-19 WO PCT/JP2022/018192 patent/WO2022224962A1/ja not_active Ceased
- 2022-04-19 US US18/287,809 patent/US20240197688A1/en active Pending
- 2022-04-19 CN CN202280022139.9A patent/CN117120093A/zh active Pending
- 2022-04-19 EP EP22791733.3A patent/EP4327826A4/en active Pending
- 2022-04-19 KR KR1020237032338A patent/KR20230172463A/ko active Pending
- 2022-04-19 CA CA3215775A patent/CA3215775A1/en active Pending
- 2022-04-19 AU AU2022262535A patent/AU2022262535A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020033919A1 (en) * | 2018-08-10 | 2020-02-13 | Diapin Therapeutics, Llc | Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders |
Non-Patent Citations (3)
| Title |
|---|
| 「欧州における高コレステロール血症治療剤の導入について｜DAIICHI-SANKYO」，[ONLINE], JPN6025037745, 7 January 2019 (2019-01-07), ISSN: 0005686380 * |
| CESARE R SIRTORI, SHIZUYA YAMASHITA, MARIA FRANCESCA GRECO, ALBERTO CORSINI, GERALD F WATTS, MASSIMI: "Recent advances in synthetic pharmacotherapies for dyslipidaemias", EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, vol. Vol.27(15), JPN6025037744, 2020, pages 1576 - 1596, ISSN: 0005686381 * |
| MANASVI GUPTA, COLIN BLUMENTHAL, SUBHANKAR CHATTERJEE, DHRUBAJYOTI BANDYOPADHYAY, VARDHMAAN JAIN, CA: "Novel emerging therapies in atherosclerosis targeting lipid metabolism", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 29, no. 6, JPN6025037746, 2020, pages 611 - 622, ISSN: 0005686379 * |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112023021643A2 (pt) | 2023-12-19 |
| US20240197688A1 (en) | 2024-06-20 |
| CN117120093A (zh) | 2023-11-24 |
| AU2022262535A1 (en) | 2023-11-16 |
| EP4327826A1 (en) | 2024-02-28 |
| KR20230172463A (ko) | 2023-12-22 |
| CA3215775A1 (en) | 2022-10-27 |
| EP4327826A4 (en) | 2025-04-23 |
| WO2022224962A1 (ja) | 2022-10-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250414 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250911 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251107 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260105 |